Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Silvia Scoccianti Daniela Greto Livia Marrazzo Beatrice Detti Michela Buglione |
| Publication date | September 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |